Met Life Investment Management, LLC Rocket Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.5 Billion
  • Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 45,859 shares of RCKT stock, worth $147,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,859
Previous 45,858 -0.0%
Holding current value
$147,207
Previous $305,000 63.28%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$2.33 - $8.01 $2 - $8
1 Added 0.0%
45,859 $112,000
Q1 2025

May 14, 2025
BUY
$6.67 - $12.72 $35,824 - $68,319
5,371 Added 13.27%
45,858 $305,000
Q4 2024

Feb 13, 2025
BUY
$11.35 - $18.82 $33,891 - $56,196
2,986 Added 7.96%
40,487 $508,000
Q2 2024

Aug 13, 2024
BUY
$20.66 - $26.72 $92,928 - $120,186
4,498 Added 13.63%
37,501 $807,000
Q1 2024

May 14, 2024
BUY
$26.16 - $30.74 $863,358 - $1.01 Million
33,003 New
33,003 $889,000
Q4 2023

Feb 14, 2024
BUY
$16.78 - $31.94 $68,747 - $130,858
4,097 Added 14.17%
33,003 $989,000
Q3 2023

May 09, 2024
BUY
$15.07 - $24.05 $10,850 - $17,316
720 Added 2.55%
28,906 $592,000
Q2 2023

Apr 29, 2024
BUY
$16.59 - $23.6 $479,550 - $682,181
28,906 New
28,906 $574,000
Q2 2023

Aug 10, 2023
BUY
$16.59 - $23.6 $11,944 - $16,992
720 Added 2.55%
28,906 $574,000
Q1 2023

May 09, 2024
BUY
$15.79 - $22.6 $445,056 - $637,003
28,186 New
28,186 $483 Million
Q4 2022

May 10, 2024
BUY
$15.5 - $22.76 $80,770 - $118,602
5,211 Added 22.68%
28,186 $551,000
Q4 2022

Mar 22, 2023
BUY
$15.5 - $22.76 $80,770 - $118,602
5,211 Added 22.68%
28,186 $551,000
Q4 2022

Feb 15, 2023
BUY
$15.5 - $22.76 $80,770 - $118,602
5,211 Added 22.68%
28,186 $551,000
Q3 2022

Jun 14, 2023
SELL
$12.37 - $18.41 $64,460 - $95,934
-5,211 Reduced 18.49%
22,975 $366,000
Q2 2022

Jun 20, 2023
SELL
$7.96 - $16.64 $41,479 - $86,711
-5,211 Reduced 18.49%
22,975 $316,000
Q1 2022

May 10, 2024
BUY
$13.16 - $23.68 $302,351 - $544,048
22,975 New
22,975 $364,000
Q1 2022

Jun 20, 2023
SELL
$13.16 - $23.68 $68,576 - $123,396
-5,211 Reduced 18.49%
22,975 $364,000
Q1 2022

Mar 22, 2023
BUY
$13.16 - $23.68 $109,241 - $196,567
8,301 Added 56.57%
22,975 $364,000
Q1 2022

May 12, 2022
BUY
$13.16 - $23.68 $109,241 - $196,567
8,301 Added 56.57%
22,975 $364,000
Q4 2021

Jun 21, 2023
SELL
$21.52 - $36.02 $290,778 - $486,702
-13,512 Reduced 47.94%
14,674 $320,000
Q3 2021

Jun 21, 2023
SELL
$27.42 - $48.97 $370,499 - $661,682
-13,512 Reduced 47.94%
14,674 $438,000
Q2 2021

Jun 21, 2023
SELL
$39.41 - $47.25 $532,507 - $638,442
-13,512 Reduced 47.94%
14,674 $649,000
Q1 2021

May 17, 2024
SELL
$43.34 - $65.91 $794,378 - $1.21 Million
-18,329 Reduced 55.54%
14,674 $651,000
Q1 2021

Jun 26, 2023
SELL
$43.34 - $65.91 $585,610 - $890,575
-13,512 Reduced 47.94%
14,674 $651 Million
Q4 2020

Jun 22, 2023
SELL
$23.3 - $59.57 $314,829 - $804,909
-13,512 Reduced 47.94%
14,674 $804,000
Q3 2020

Jun 26, 2023
SELL
$20.5 - $28.59 $276,996 - $386,308
-13,512 Reduced 47.94%
14,674 $335,000
Q2 2020

May 24, 2024
SELL
$13.32 - $22.61 $244,142 - $414,418
-18,329 Reduced 55.54%
14,674 $307 Million
Q2 2020

Jun 26, 2023
SELL
$13.32 - $22.61 $179,979 - $305,506
-13,512 Reduced 47.94%
14,674 $307,000
Q1 2020

Jul 12, 2023
SELL
$9.71 - $25.11 $131,201 - $339,286
-13,512 Reduced 47.94%
14,674 $204,000
Q4 2019

Jul 12, 2023
SELL
$11.07 - $24.23 $149,577 - $327,395
-13,512 Reduced 47.94%
14,674 $333,000
Q3 2019

Jul 12, 2023
SELL
$10.85 - $14.78 $146,605 - $199,707
-13,512 Reduced 47.94%
14,674 $170,000
Q3 2019

Mar 22, 2023
BUY
$10.85 - $14.78 $45,483 - $61,957
4,192 Added 39.99%
14,674 $170,000
Q3 2019

Nov 14, 2019
BUY
$10.85 - $14.78 $45,483 - $61,957
4,192 Added 39.99%
14,674 $171,000
Q2 2019

Jul 12, 2023
SELL
$15.0 - $19.81 $202,680 - $267,672
-13,512 Reduced 47.94%
14,674 $220,000
Q1 2019

Jul 13, 2023
SELL
$13.45 - $19.01 $238,118 - $336,553
-17,704 Reduced 62.81%
10,482 $183,000
Q4 2018

Jul 13, 2023
SELL
$11.21 - $23.53 $198,461 - $416,575
-17,704 Reduced 62.81%
10,482 $155,000
Q4 2018

Mar 22, 2023
SELL
$11.21 - $23.53 $64,816 - $136,050
-5,782 Reduced 35.55%
10,482 $155,000
Q4 2018

Feb 14, 2019
SELL
$11.21 - $23.53 $64,816 - $136,050
-5,782 Reduced 35.55%
10,482 $155,000
Q3 2018

Jul 13, 2023
SELL
$18.5 - $25.49 $327,524 - $451,274
-17,704 Reduced 62.81%
10,482 $258,000
Q3 2018

Mar 22, 2023
SELL
$18.5 - $25.49 $220,557 - $303,891
-11,922 Reduced 42.3%
16,264 $400,000
Q3 2018

Nov 14, 2018
BUY
$18.5 - $25.49 $300,884 - $414,569
16,264 New
16,264 $400,000

Others Institutions Holding RCKT

# of Institutions
221
Shares Held
98.4M
Call Options Held
611K
Put Options Held
474K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $243M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email